• Login
    View Item 
    •   NWU-IR Home
    • Research Output
    • Faculty of Natural and Agricultural Sciences
    • View Item
    •   NWU-IR Home
    • Research Output
    • Faculty of Natural and Agricultural Sciences
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Reverse flows within the pharmaceutical supply chain: a classificatory review from the perspective of end-of-use and end-of-life medicines

    Thumbnail
    Date
    2019
    Author
    Viegas, Cláudia Viviane
    Bond, Alan
    Vaz, Caroline Rodrigues
    Bertolo, Rubem Joao
    Metadata
    Show full item record
    Abstract
    The Pharmaceutical Supply Chain (PSC) is responsible for considerable environmental and product-value impacts. However, studies on the reverse flows of PSC do not capture the diverse routes of end-of-use and end-of-life medicines (EOU/EOL-M) and how the constraints in the forward supply chain processes and operations impact such reverse flows. This research proposes a classificatory review in which three categories of reverse flows are identified: donations, Reverse Logistics (RL) and Circular Economy (CE). Donations are characterized by explicit philanthropic acts involving corporate reputation or by emergency humanitarian action. RL is boosted by regulatory issues and restricted by business imperatives of the PSC. CE is characterized by informal loops of not expired medicines, mainly due to health professionals’ initiatives (although this may not be clear to participants). This classification emerged from content analysis of 2622 references found in six databases, from which 127 were selected. Three questions guided the review in each category: (i) what are the elements of the forward PSC processes that impact PSC reverse flows?; (ii) in what stages of the PSC are the reverse flows identified?; (iii) what does the academic literature recommend for improving PSC reverse flows? The literature shows that excessive amounts and inappropriate types of medicines hinder donations. Inventory planning and quality control problems are the main difficulties for medicines RL. The circularity of EOU-M is affected significantly by frequent changes of patient therapies and health conditions, and by failures of healthcare agents in monitoring prescriptions. The proposed classification suggests that the circularity of not expired medicines is not yet researched in the field of logistics, supply chain and procurement, and it is scarcely considered in engineering, and business and management areas, which evokes a call for future research agenda
    URI
    http://hdl.handle.net/10394/33431
    https://www.sciencedirect.com/science/article/pii/S0959652619325752#!
    https://doi.org/10.1016/j.jclepro.2019.117719
    Collections
    • Faculty of Natural and Agricultural Sciences [4855]

    Copyright © North-West University
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of NWU-IR Communities & CollectionsBy Issue DateAuthorsTitlesSubjectsAdvisor/SupervisorThesis TypeThis CollectionBy Issue DateAuthorsTitlesSubjectsAdvisor/SupervisorThesis Type

    My Account

    LoginRegister

    Copyright © North-West University
    Contact Us | Send Feedback
    Theme by 
    Atmire NV